Delivery Order SPE2DB20D3111-SPE2DB25FA6RU
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.99 firm fixed-price delivery order is for the supply of 4,566,703,864 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.36, is a delivery order for 4,567,154,351 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The contract has a completion date of February 5, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order valued at $1,494.60 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,563,471,961 units of the drug Oseltamivir Phosphate 75 mg capsules, an antiviral medication used to treat and prevent influenza. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is a firm fixed-price contract with no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,203,037 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The contract has a firm fixed price of $1,619.64 and an ultimate completion date of January 2, 2024. This award is part of a larger DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,378.24, is for the delivery of 4,567,037,738 units of the antiviral drug Oseltamivir Phosphate 75 mg capsules. The contract is a firm fixed-price Delivery Order with a completion date of January 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award, valued at $1,317.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,562,181,703 units of Oseltamivir Phosphate 75 mg capsules, with an ultimate completion date of September 15, 2023. The contract is not designated with a set-aside requirement, indicating open competition. It is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,732.12 firm fixed-price delivery order is for the supply of 4,558,866,552 units of the drug Oseltamivir Phosphate 30 mg capsules, with an ultimate completion date of October 25, 2022. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,087.36, is for the procurement of 4,567,218,221 units of Oseltamivir Phosphate 75 mg Capsules. The contract has a period of performance through February 11, 2025 and was awarded on February 10, 2025. This order is placed against AmerisourceBergen's existing Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,035.78 firm fixed-price delivery order contract is for the supply of 4,562,562,995 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of October 24, 2023 and was awarded on October 23, 2023. This appears to be a task order under a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Oseltamivir Phosphate 75 mg capsules. The $5,983.30 firm-fixed-price delivery order has a completion date of November 30, 2022 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a wide range of pharmaceutical...